Omics-based biomarkers for diagnosis and prediction of kidney allograft rejection

키워드

참고문헌 (76)

1. Wolfe RA, "Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant", N Engl J Med, 341, pp.1725~1730 (1999)
2. Port FK, "Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients", JAMA, 270, pp.1339~1343 (1993)
3. Sehoon Park, "Characteristics of kidney transplantation recipients over time in South Korea", The Korean Journal of Internal Medicine, 35(6), pp.1457~1467 (2020), 대한내과학회[DOI]
4. 박요한, "Kidney transplantation in highly sensitized recipients", Kidney Research and Clinical Practice, 40(3), pp.355~370 (2021), 대한신장학회[DOI]
5. Morris PJ, "Transplantation : a medical miracle of the 20th century", N Engl J Med, 351, pp.2678~2680 (2004)
6. AbdElhalim Mohamed S., "The impact of omeprazole on mycophenolate pharmacokinetics in kidney transplant recipients", Kidney Research and Clinical Practice, 39(4), pp.479~486 (2020), 대한신장학회[DOI]
7. 전홍제, "Outcomes of end-stage renal disease patients on the waiting list for deceased donor kidney transplantation: A single-center study", Kidney Research and Clinical Practice, 38(1), pp.116~123 (2019), 대한신장학회[DOI]
8. Chung BH, "Clinical impact of the baseline donor-specific anti-human leukocyte antigen antibody measured by Luminex single antigen assay in living donor kidney transplant recipients after desensitization therapy", Transpl Int, 27, pp.49~59 (2014)
9. 정현주, "Diagnosis of renal transplant rejection: Banff classification and beyond", Kidney Research and Clinical Practice, 39(1), pp.17~31 (2020), 대한신장학회[DOI]
10. Halloran PF, "Immunosuppressive drugs for kidney transplantation", N Engl J Med, 351, pp.2715~2729 (2004)
11. Byung Ha Chung, "Clinical significance of Th17 cells in kidney transplantation", The Korean Journal of Internal Medicine, 33(5), pp.860~866 (2018), 대한내과학회[DOI]
12. Naesens M, "Precision transplant medicine : biomarkers to the rescue", J Am Soc Nephrol, 29, pp.24~34 (2018)
13. Lim JH, "Excellent outcome after desensitization in high immunologic risk kidney transplantation", PLoS One, 14, pp.e0222537~ (2019)
14. Potter Steven R., "Remote monitoring using donor-derived, cell-free DNA after kidney transplantation during the coronavirus disease 2019 pandemic", Kidney Research and Clinical Practice, 39(4), pp.495~500 (2020), 대한신장학회[DOI]
15. Hyunjoo Bae, "Usefulness of BK virus-specific interferon-γ enzyme-linked immunospot assay for predicting the outcome of BK virus infection in kidney transplant recipients", The Korean Journal of Internal Medicine, 36(1), pp.164~174 (2021), 대한내과학회[DOI]
16. Taeeun Kim, "Diagnostic usefulness of the cytomegalovirus (CMV)-specific T cell-based assay for predicting CMV infection after kidney transplant", The Korean Journal of Internal Medicine, 35(2), pp.438~448 (2020), 대한내과학회[DOI]
17. 박우영, "Clinical significance of serum galactose-deficient immunoglobulin A1 for detection of recurrent immunoglobulin A nephropathy in kidney transplant recipients", Kidney Research and Clinical Practice, 40(2), pp.317~324 (2021), 대한신장학회[DOI]
18. Glassock RJ, "Con : kidney biopsy. An irreplaceable tool for patient management in nephrology", Nephrol Dial Transplant, 30, pp.528~531 (2015)
19. Kidd JM, "Mapping and sequencing of structural variation from eight human genomes", Nature, 453, pp.56~64 (2008)
20. Naesens M, "Molecular diagnostics in transplantation", Nat Rev Nephrol, 6, pp.614~628 (2010)
21. Horgan RP, "‘Omic’ technologies : genomics, transcriptomics, proteomics and metabolomics", Obstet Gynaecol, 13, pp.189~195 (2011)
22. Rhee EP, "How omics data can be used in nephrology", Am J Kidney Dis, 72, pp.129~135 (2018)
23. Baltimore D, "Our genome unveiled", Nature, 409, pp.814~816 (2001)
24. Stapleton CP, "Using omics to explore complications of kidney transplantation", Transpl Int, 31, pp.251~262 (2018)
25. Mele M, "Human genomics. The human transcriptome across tissues and individuals", Science, 348, pp.660~665 (2015)
26. Gunesacar R, "VEGF 936 C", T gene polymorphism in renal transplant recipients : association of the T allele with good graft outcome, 2007, pp.68, 599~602
27. Theodorescu D, "Mass spectrometry based proteomics in urine biomarker discovery", World J Urol, 25, pp.435~443 (2007)
28. Hasin Y, "Multi-omics approaches to disease", Genome Biol, 18, pp.83~ (2017)
29. Vlahou A, "Proteomic approaches in the search for disease biomarkers", J Chromatogr B Analyt Technol Biomed Life Sci, 814, pp.11~19 (2005)
30. Wang D, "Omics technologies for kidney disease research", Anat Rec(Hoboken), 303, pp.2729~2742 (2020)
31. Liu Y, "On the dependency of cellular protein levels on mRNA abundance", Cell, 165, pp.535~550 (2016)
32. Mann M, "Proteomic analysis of post-translational modifications", Nat Biotechnol, 21, pp.255~261 (2003)
33. Urbanczyk-Wochniak E, "Parallel analysis of transcript and metabolic profiles : a new approach in systems biology", EMBO Rep, 4, pp.989~993 (2003)
34. Emwas AHM, "NMR-based metabolomics in human disease diagnosis : applications, limitations, and recommendations", Metabolomics, 9, pp.1048~1072 (2013)
35. Everly MJ, "Incidence and impact of de novo donor-specific alloantibody in primary renal allografts", Transplantation, 95, pp.410~417 (2013)
36. Hourmant M, "Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation", J Am Soc Nephrol, 16, pp.2804~2812 (2005)
37. Mohan S, "Donor-specific antibodies adversely affect kidney allograft outcomes", J Am Soc Nephrol, 23, pp.2061~2071 (2012)
38. Loupy A, "Transplantation : donor-specific HLA antibodies and renal allograft failure", Nat Rev Nephrol, 9, pp.130~131 (2013)
39. Ghisdal L, "Genome-wide association study of acute renal graft rejection", Am J Transplant, 17, pp.201~209 (2017)
40. Oetting WS, "Analysis of 75 candidate SNPs associated with acute rejection in kidney transplant recipients : validation of rs2910164 in microRNA MIR146A", Transplantation, 103, pp.1591~1602 (2019)
41. Steers NJ, "Genomic mismatch at LIMS1 locus and kidney allograft rejection", N Engl J Med, 380, pp.1918~1928 (2019)
42. Dorr CR, "Genetics of acute rejection after kidney transplantation", Transpl Int, 31, pp.263~277 (2018)
43. Israni A, "Single-nucleotide polymorphisms, acute rejection, and severity of tubulitis in kidney transplantation, accounting for center-to-center variation", Transplantation, 90, pp.1401~1408 (2010)
44. Li B, "Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine", N Engl J Med, 344, pp.947~954 (2001)
45. Muthukumar T, "Messenger RNA for FOXP3 in the urine of renal-allograft recipients", N Engl J Med, 353, pp.2342~2351 (2005)
46. Suthanthiran M, "Urinary-cell mRNA profile and acute cellular rejection in kidney allografts", N Engl J Med, 369, pp.20~31 (2013)
47. Friedewald JJ, "Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant", Am J Transplant, 19, pp.98~109 (2019)
48. Roedder S, "The kSORT assay to detect renal transplant patients at high risk for acute rejection : results of the multicenter AART study", PLoS Med, 11, pp.e1001759~ (2014)
49. Zhang W, "A peripheral blood gene expression signature to diagnose subclinical acute rejection", J Am Soc Nephrol, 30, pp.1481~1494 (2019)
50. Christakoudi S, "Development of a multivariable gene-expression signature targeting T-cell-mediated rejection in peripheral blood of kidney transplant recipients validated in cross-sectional and longitudinal samples", EBioMedicine, 41, pp.571~583 (2019)
51. El Fekih R, "Discovery and validation of a urinary exosome mRNA signature for the diagnosis of human kidney transplant rejection", J Am Soc Nephrol, 32, pp.994~1004 (2021)
52. Seo JW, "Non-invasive diagnosis for acute rejection using urinary mRNA signature reflecting allograft status in kidney transplantation", Front Immunol, 12, pp.656632~ (2021)
53. Anglicheau D, "MicroRNA expression profiles predictive of human renal allograft status", Proc Natl Acad Sci U S A, 106, pp.5330~5335 (2009)
54. Tao J, "Serum microRNA-99a helps detect acute rejection in renal transplantation", Transplant Proc, 47, pp.1683~1687 (2015)
55. Lorenzen JM, "Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients", Am J Transplant, 11, pp.2221~2227 (2011)
56. Vitalone MJ, "Transcriptional perturbations in graft rejection", Transplantation, 99, pp.1882~1893 (2015)
57. O’Riordan E, "Characterization of urinary peptide biomarkers of acute rejection in renal allografts", Am J Transplant, 7, pp.930~940 (2007)
58. Ling XB, "Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection", J Am Soc Nephrol, 21, pp.646~653 (2010)
59. Ziegler ME, "Apolipoprotein A1 and C-terminal fragment of α-1 antichymotrypsin are candidate plasma biomarkers associated with acute renal allograft rejection", Transplantation, 92, pp.388~395 (2011)
60. Sigdel TK, "The identification of novel potential injury mechanisms and candidate biomarkers in renal allograft rejection by quantitative proteomics", Mol Cell Proteomics, 13, pp.621~631 (2014)
61. Lim JH, "Novel urinary exosomal biomarkers of acute T cell-mediated rejection in kidney transplant recipients : a cross-sectional study", PLoS One, 13, pp.e0204204~ (2018)
62. Blydt-Hansen TD, "Urinary metabolomics for noninvasive detection of borderline and acute T cell-mediated rejection in children after kidney transplantation", Am J Transplant, 14, pp.2339~2349 (2014)
63. Blydt-Hansen TD, "Urinary metabolomics for noninvasive detection of antibody-mediated rejection in children after kidney transplantation", Transplantation, 101, pp.2553~2561 (2017)
64. Sigdel TK, "Targeted urine metabolomics for monitoring renal allograft injury and immunosuppression in pediatric patients", J Clin Med, 9, pp.2341~ (2020)
65. Kim SY, "Urinary metabolomic profiling for noninvasive diagnosis of acute T cell-mediated rejection after kidney transplantation", J Chromatogr B Analyt Technol Biomed Life Sci, 1118-1119, pp.157~163 (2019)
66. O’Connell PJ, "Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury : a multicentre, prospective study", Lancet, 388, pp.983~993 (2016)
67. Li L, "Novel therapeutics identification for fibrosis in renal allograft using integrative informatics approach", Sci Rep, 7, pp.39487~ (2017)
68. Jung HY, "Potential urinary extracellular vesicle protein biomarkers of chronic active antibody-mediated rejection in kidney transplant recipients", J Chromatogr B Analyt Technol Biomed Life Sci, 1138, pp.121958~ (2020)
69. Quaglia M, "Recent advances on biomarkers of early and late kidney graft dysfunction", Int J Mol Sci, 21, pp.5404~ (2020)
70. CaliffRM, "Biomarker definitions and their applications", Exp Biol Med(Maywood), 243, pp.213~221 (2018)
71. Salvadori M, "Biomarkers in renal transplantation : an updated review", World J Transplant, 7, pp.161~178 (2017)
72. Verhoeven J, "Liquid biopsies to monitor solid organ transplant function : a review of new biomarkers", Ther Drug Monit, 40, pp.515~525 (2018)
73. Zhang W, "Integrating multiple ‘omics’ analysis for microbial biology : application and methodologies", Microbiology(Reading), 156(Pt 2), pp.287~301 (2010)
74. Cao Y, "Integrative analysis of prognostic biomarkers for acute rejection in kidney transplant recipients", Transplantation, 105, pp.1225~1237 (2021)
75. Niel O, "Artificial intelligence in nephrology : core concepts, clinical applications, and perspectives", Am J Kidney Dis, 74, pp.803~810 (2019)
76. Briganti G, "Artificial intelligence in medicine: today and tomorrow", Front Med(Lausanne), 7, pp.27~ (2020)

관련 논문AI추천